Funding for this research was provided by:
National Institute on Drug Abuse (K23DA055695)
National Institute on Drug Abuse (R25DA037190)
National Institute of Mental Health (P50 MH126219)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (P50 MH126219.)
Article History
Received: 13 November 2023
Accepted: 20 March 2024
First Online: 9 April 2024
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.